Carla Proietti

Dr. Proietti completed her PhD in 2011 through the Marie Curie International PhD Program, undertaking research across Italy, the United Kingdom, and Uganda. She has since held research appointments at Imperial College London, the London School of Hygiene and Tropical Medicine, the Wellcome Trust Sanger Institute, James Cook University, and QIMR Berghofer Medical Research Institute. Her interdisciplinary training spans physics, molecular immunology, epidemiology, and data science, enabling her to bridge experimental and computational approaches in global health research.

Her work focuses particularly on systems immunology approaches to malaria, applying high-throughput immune profiling and machine learning to identify immune signatures associated with protection and infection, and to inform next-generation malaria vaccine development. In parallel, she investigates immune responses to Epstein–Barr virus (EBV) and their role in immune-mediated diseases, with the goal of developing early diagnostic and prognostic biomarkers.
Dr. Proietti has led and contributed to international collaborative studies supported by organizations including the U.S. National Institutes of Health (NIH), NFMRI, and MS Australia. She has authored approximately 40 peer-reviewed publications in journals such as Nature Medicine, Cell Host & Microbe, Clinical Cancer Research, and The Lancet Microbe.

Dr. Proietti joined the MESA Correspondents Program as Senior Editor in 2024 during the Molecular Approaches to Malaria (MAM) conference, where she contributes to highlighting emerging research and perspectives from the global malaria community.